Table 1 Characteristic of treatment and patients
AGE | MEDIAN | RANGE |
|---|---|---|
Patients | 57 | 38 – 82 |
BRAIN METASTASES SCORE | NUMBER | % |
BM-S O | 34 | 19.5 |
B M-S 1 | 54 | 31 |
BM-S 2 | 61 | 35 |
BM-S 3 | 25 | 14.5 |
KPS | ||
< 70 | 89 | 51.1 |
>= 70 | 85 | 48.8 |
SURGICAL RESECTION | ||
Yes | 27 | 15.5 |
No | 147 | 84.5 |
DOSE(Gy) FRACTIONATION (fr) | ||
40 Gy/20 fr | 66 | 37.9 |
30 Gy/10 fr | 108 | 62.1 |
NUMBER LESIONS | ||
Single | 66 | 37.9 |
Multiple | 108 | 62.1 |
CHEMOTHERAPY | ||
Yes | 32 | 18.3 |
No | 142 | 81.6 |
RPA CLASS | ||
Class I | 39 | 22.4 |
Class II | 46 | 26.4 |
Class III | 89 | 51.2 |
LOCALIZATION | ||
Supratentorial | 140 | 80.5 |
Infratentorial | 24 | 13.8 |
Both | 10 | 5.7 |
PRIMARY DISEASE CONTROL | ||
Yes | 86 | 49.4 |
No | 88 | 50.6 |
EXTRACRANIAL METASTASES | ||
Controlled | 80 | 46 |
No Controlled | 94 | 54 |